Sanofi Tries To Quash Bristol Rumors; M&A Efforts Center On Biotech, Japan
This article was originally published in PharmAsia News
Executive Summary
Sanofi-Aventis' merger and acquisition efforts will focus on biotech firms and Japanese companies, CEO Gerard Le Fur maintained Feb. 13